Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-11-25T11:35:27.277Z Has data issue: false hasContentIssue false
  • English
  • Français

A Theory of the Mechanism of Cerebral Vasospasm and Its Reversal, the Role of Calcium and Cyclic AMP

Published online by Cambridge University Press:  18 September 2015

Eric W. Peterson  and
Richard Leblanc
Eric W. Peterson*
Affiliation:
Division of Neurosurgery, University of Ottawa, Medical School
Richard Leblanc
Affiliation:
Division of Neurosurgery, University of Ottawa, Medical School
*
703-1081 Carling Avenue, Ottawa, Ontario KIY 4G2 Canada
Rights & Permissions [Opens in a new window]

Summary:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

It is proposed that the basic mechanism of vasospasm which sometimes follows subarachnoid hemorrhage is dependent on increased free intracellular calcium ion produced by spasmogens from closely applied extravasated blood. Relaxation of this spasm occurs when the intracellular cyclic AMP levels are raised, resulting in sequestration of calcium ion by the vascular smooth muscle cell sarcoplasmic reticulum.

Type
Research Article
Information
Canadian Journal of Neurological Sciences , Volume 3 , Issue 4 , November 1976 , pp. 223 - 226
Copyright
Copyright © Canadian Neurological Sciences Federation 1976

References

Allen, J.S., Henderson, L.M.. Chou, S.N. (1974). Cerebral arterial spasm. Journal of Neurosurgery: 40. 433–458.CrossRefGoogle ScholarPubMed
Allen, J.S., Gross, C.J., Henderson, L.M. and Chou, S.N. (1976). Cerebral arterial spasm, Part 4. Journal of Neurosurgery: 44, 585–593.CrossRefGoogle ScholarPubMed
Andersson, R.G.G. (1972). Cyclic AMP and calcium ions in mechanical and metabolic responses of smooth muscles; influence of some hormones and drugs. Acta. Physiol. Scand. Supp.382.Google ScholarPubMed
Arutinov, A.L., Barron, M.A., Magorova, M.A. (1974). The role of mechanical factors in the pathogenesis of short term and prolonged spasm in the cerebral arteries. Journal of Neurosurgery: 40, 451–458.Google Scholar
Barrett-Bee, K.J., Green, L.R. (1975). The relationship between prostaglandin release and cyclic AMP levels during anaphylaxis (Anaphylaxis) in the guinea pig. Prostaglandin: 10, 589–592.CrossRefGoogle ScholarPubMed
Blum, J.J. Editor (1970). Biogenic amines as physiological regulators. A symposium held under the auspices of the Society of General Physiologists at the Marine Biological Laboratory. Woods-hole, Mass. Aug. 29 - Sept. 1, 1969. Prentice Hall and Comp. New Jersey.Google Scholar
Bohr, D.F. (1973). Vascular smooth muscle updated. Circ. Res. 32, 665–672.CrossRefGoogle ScholarPubMed
Borgeat, P., Labrie, F., Garneau, P. (1975). Characteristics of action of prostaglandins on cyclic AMP accumulation in rat anterior pituitary gland. Can. J. Biochem: 53, 455–460.CrossRefGoogle ScholarPubMed
Cooper, J.R., Bloom, F.E.. Rott, R.H. (1974). The biochemical basis of Neuropharmacology, New York, Oxford University Press, Second Edition.Google Scholar
Drake, C.G. (1976). Stroke: 7, 238.Google Scholar
Echlin, F.A. (1951). Current concepts in the etiology and treatment of vasospasm. Clin. Neurosurg: 15, 133–160.CrossRefGoogle Scholar
Ecker, A., Riemenscheider, P.A. (1951). Arteriographie demonstration of spasm of the intracranial arteries with special reference to saccular arterial aneurysms. Journal of Neurosurgery: 8, 660–667.CrossRefGoogle Scholar
Edvinson, L., Owman, C. (1974). Pharmacological characterization of alpha and beta receptors mediating vasomotor response of cerebral arteries in vitro. Circ: Res. 35, 835“849.Google Scholar
Flamm, E.S., Kin, J., Lin, J. (1975). Phosphodiesterase inhibitors and cerebral vasospasm. Arch. Nurol: 32, 569–713CrossRefGoogle ScholarPubMed
Fisher, C.M. Personal Communication.Google Scholar
Goodman, L.F. and Gilman, A. (1970). The Pharmacological basis of therapeutics. The MacMillan Co. Fourth Edition.Google Scholar
Kapp, J., Mahaley, M.S., Odom, G.L. (1968). Cerebral arterial spasm. Journal of Neurosurgery: 29, 331–356.CrossRefGoogle ScholarPubMed
Katz, A.N. (1975). Congestive heart failure. Role of altered myocardial cellular control. New England Journal of Medicine: 293, 1184–1191.CrossRefGoogle ScholarPubMed
Langfitt, W. (1974). Cerebral circulation and metabolism. Summary of International Symposium June 6–10, 1973. Journal of Neurosurgery: 40, 561–576.CrossRefGoogle ScholarPubMed
Latorre, E., Patrono, C, Fortuna, A. and Grossi-Belloni, D. (1974). Role of prostaglandin F2 in human central vasospasm. Journal of Neurosurgery: 41, 293–299.Google Scholar
Lowe, I.F., and Gilboe, D.D. (1971). Demonstration of alpha and beta adrenergic receptors in canine cerebral vasculature. Stroke: 2, 193–200.CrossRefGoogle ScholarPubMed
Pelofsky, S., Jacobson, E.D. and Fisher, R.G. (1972). Effects of PGEi on experimental cerebral vasospasm. Journal of Neurosurgery: 36, 634.CrossRefGoogle Scholar
Peerless, S., Yasargil, M. (1971). Adrenergic innervation of the cerebral blood vessels in the rabbit. Journal of Neurosurgery: 35, 148–154.CrossRefGoogle ScholarPubMed
Peterson, E.W., Metuzals, J., Johnson, D.H. (1969). The relief of cerebral vasospasm by topically applied ethylene diamine tetra acetic acid (EDTA) Excerpta Medica. International Congress Series: 192, 72.Google Scholar
Peterson, E.W., Searle, R., Mandy, F.F., Leblanc, R. and Bosc, M.(Waddell, W.G.),(1973a). A chronic experimental model for the production of subarachnoid hemorrhage. British Journal of Surgery.Google Scholar
Peterson, E.W., Mandy, F.F., Searle, R. and Leblanc, R. (1973b). Reversal of cerebral vasospasm. Lancet: 1, 1513.CrossRefGoogle ScholarPubMed
Peterson, E.W., Searle, R., Mandy, F., Leblanc, R. and Bosc, M. (1973c). Investigation of cerebral vasospasm and its reversal using dibutyryl cyclic AMP and theophylline. J. Excerpta Medica International Congress Series No. 293, the V International Congress of Neurological Surgery, Tokyo, Japan, October.Google Scholar
Peterson, E.W., Searle, R., Mandy, F.F. and Leblanc, R. (1973d). The reversal of experimental vasospasm by 3’5’-adenosine monophosphate. Journal of Neurosurgery: December, 39, 6.CrossRefGoogle Scholar
Peterson, E.W., Leblanc, R., Searle, R. and Mandy, F. (1975a). Some considerations on cerebral vasospasm. Am. Heart 1: 89, 124–126.CrossRefGoogle Scholar
Peterson, E.W., Leblanc, R., Lebel, F. (1975b). Cyclic adenosine Monophosphate antagonism of prostaglandin induced vasospasm. Surg. Neurol.: 4, 490–496.Google ScholarPubMed
Pool, J.L. (1958). Cerebral vasospasm. New England Journal of Medicine. 254, 1259–1264.CrossRefGoogle Scholar
Robison, A.G., Butcher, R.W., Sutherland, E.W. (1971a). Cyclic AMP, New York, Academic Press.Google ScholarPubMed
Robison, A.G., Butcher, R.W., Sutherland, E.W. (1971b). Adenyl-cyclase as an adrenergic receptor. Ann. N.Y. Acad. Sci.: 185, 703–723.Google Scholar
Somlyo, A.P., Somlyo, A.V. (1970). Vascular smooth muscle: II Pharmacology and normal and hypertensive vessels. Pharmacol. Rev. 22, 353.Google Scholar
Triner, L., Vulliemoz, L., Schwartz, I., Nahas, G.G. (1970). Cyclic phosphodiestrase activity and the action of papaverine. Biochem. Biophys. Res. Commun.: 40, 64–69.CrossRefGoogle Scholar
White, R.P., Hagen, A.A. Morgan, H., et al (1975). Experimental study on the genesis of cerebral vasospasm. Stroke: 6, 52–57.CrossRefGoogle Scholar
Wolfe, L.S., Mamer, O.A. (1975). Measurement of prostaglandin F: levels in human cerebrospinal fluid in normal and pathological conditions. Prostaglandins: 9, 183–192.CrossRefGoogle ScholarPubMed